Zobrazeno 1 - 10
of 231
pro vyhledávání: '"T. A. Thomson"'
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectiveThe objective of this study is to determine whether restricted cervical mobility in ankylosing spondylitis (AS) is associated with increased fall frequency or fear of falling.MethodsA total of 134 AS patients and 199 age- and gender-matched
Externí odkaz:
https://doaj.org/article/92cc79c3a040481eab72bebc30d78918
Autor:
Glen T D Thomson, In-Ho Song, Stephen Hall, Ricardo Blanco, Filip Van den Bosch, Louis Bessette, Cristiano A. F. Zerbini, Ryan DeMasi, Yihan Li, Roy Fleischmann, Jeffrey Enejosa, Y. Song
Publikováno v:
Annals of the Rheumatic Diseases
ANNALS OF THE RHEUMATIC DISEASES
ANNALS OF THE RHEUMATIC DISEASES
ObjectivesTo evaluate efficacy and safety of immediate switch from upadacitinib to adalimumab, or vice versa, in patients with rheumatoid arthritis with non-response or incomplete-response to the initial therapy.MethodsSELECT-COMPARE randomised patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa88f0861816f767a2bab1c98ccf4806
https://doi.org/10.1136/annrheumdis-2020-218412
https://doi.org/10.1136/annrheumdis-2020-218412
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:383-391
Background:Assessment of individuals at risk for falling entails comprehensive neurological and vestibular examinations. Chronic limitation in cervical mobility reduces gaze accuracy, potentially impairing navigation through complex visual environmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7025ade90a3693edc5d3c3648754f3a
https://doi.org/10.1017/cjn.2020.186
https://doi.org/10.1017/cjn.2020.186
News media coverage of Indigenous Australian peoples and perspectives is often absent or, when present, unfair or shallow in context or understanding. This raises the question of how much ‐ and what kind of ‐ exposure to Indigenous knowledges and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dfa7fae488c3a4a8d2b7ef8a36f7d7
Autor:
In-Ho Song, Bernard Combe, Y. Song, Karel Pavelka, Alan Friedman, Stephen Hall, Tim Shaw, Paul Emery, Tsutomu Takeuchi, Eduardo Mysler, Glen T. D. Thomson, Andrea Everding
Publikováno v:
Rheumatology. 59
Background Across all phase 3 studies, treatment with upadacitinib (UPA), a JAK1-selective inhibitor, was associated with significantly higher remission (REM) rates, compared to placebo (PBO) or active comparators, in RA patients who were methotrexat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ca205a046aefd63ad2110c7753b6f98
https://doi.org/10.1093/rheumatology/keaa111.195
https://doi.org/10.1093/rheumatology/keaa111.195
Autor:
Pakanen, V. (Veli‐Matti), Rönkä, N. (Nelli), Leslie, T. R. (Thomson Robert), Blomqvist, D. (Donald), Koivula, K. (Kari)
Effects of tracking devices on survival are generally considered to be small. However, most studies to date have been conducted over a time‐period of only one year, neglecting the possible accumulation of negative effects and consequently stronger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::f1b4b62d74e5dc8cf2edce59cf782a4a
http://urn.fi/urn:nbn:fi-fe202101192101
http://urn.fi/urn:nbn:fi-fe202101192101
Autor:
Sebastian Meerwein, John J. Cush, Glen T. D. Thomson, Casey Schlacher, Kun Chen, Michael E. Weinblatt
Publikováno v:
Poster Presentations.
Background Upadacitinib (UPA), a JAK1-selective inhibitor, demonstrated efficacy in the SELECT-BEYOND study in patients (pts) with moderate to severe rheumatoid arthritis (RA) on a stable dose of csDMARDs who had inadequate response (IR) or intoleran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2183d67ec7e3f510eb1b0f10e75efdb
https://doi.org/10.1136/annrheumdis-2019-eular.3083
https://doi.org/10.1136/annrheumdis-2019-eular.3083
Autor:
Tim Shaw, Bernard Combe, Eduardo Mysler, Alan Friedman, Andrea Everding, In-Ho Song, Y. Song, Karel Pavelka, Stephen Hall, Glen T D Thomson, Paul Emery, Tsutomu Takeuchi
Publikováno v:
Poster Presentations.
Background Across all phase 3 studies, treatment with upadacitinib (UPA), a JAK1-selective inhibitor, was associated with significantly higher remission (REM) rates, compared to placebo (PBO) or active comparators, in RA patients (pts) who were metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d96daac770970afa9ca06b2612b6215
https://doi.org/10.1136/annrheumdis-2019-eular.2003
https://doi.org/10.1136/annrheumdis-2019-eular.2003
Autor:
Roy Fleischmann, Glen T. D. Thomson, LI Yihan, Ricardo Blanco, Ryan DeMasi, J. Enejosa, Cristiano A. F. Zerbini, Stephen Hall, In-Ho Song, Mark C. Genovese, Filip Van den Bosch
Publikováno v:
Oral Presentations.
Background Initiating advanced therapy for rheumatoid arthritis (RA) patients (pts) with a bDMARD or a Janus kinase (JAK) inhibitor is recommended if remission or low disease activity (LDA) is not achieved with csDMARDs.1,2 While data show that pts a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9820af834ff3454b6a6f1fb77408a394
https://doi.org/10.1136/annrheumdis-2019-eular.2886
https://doi.org/10.1136/annrheumdis-2019-eular.2886
Autor:
T V, Campbell, T T, Thomson
Publikováno v:
The Indian Medical Gazette
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10dbf62288244ff5d08ae585bf74ad8e
https://pubmed.ncbi.nlm.nih.gov/29005344
https://pubmed.ncbi.nlm.nih.gov/29005344